Your browser doesn't support javascript.
loading
The forgotten people: Hepatitis B virus (HBV) infection as a priority for the inclusion health agenda.
Martyn, Emily; Eisen, Sarah; Longley, Nicky; Harris, Philippa; Surey, Julian; Norman, James; Brown, Michael; Sultan, Binta; Maponga, Tongai G; Iwuji, Collins; Flanagan, Stuart; Ghosh, Indrajit; Story, Alistair; Matthews, Philippa C.
Afiliación
  • Martyn E; The Francis Crick Institute, London, United Kingdom.
  • Eisen S; London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Longley N; Hospital for Tropical Diseases, Division of Infection, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Harris P; Hospital for Tropical Diseases, Division of Infection, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Surey J; London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Norman J; Hospital for Tropical Diseases, Division of Infection, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Brown M; Department of Infectious Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Sultan B; Find & Treat Service, Division of Infection, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Maponga TG; Find & Treat Service, Division of Infection, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Iwuji C; Institute of Global Health, University College London, London, United Kingdom.
  • Flanagan S; Universidad Autonoma de Madrid, Ciudad Universitaria de Cantoblanco, Madrid, Spain.
  • Ghosh I; Find & Treat Service, Division of Infection, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Story A; London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • Matthews PC; Department of Infectious Diseases, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Elife ; 122023 02 09.
Article en En | MEDLINE | ID: mdl-36757862
Hepatitis B virus (HBV) infection represents a significant global health threat, accounting for 300 million chronic infections and up to 1 million deaths each year. HBV disproportionately affects people who are under-served by health systems due to social exclusion, and can further amplify inequities through its impact on physical and mental health, relationship with stigma and discrimination, and economic costs. The 'inclusion health' agenda focuses on excluded and vulnerable populations, who often experience barriers to accessing healthcare, and are under-represented by research, resources, interventions, advocacy, and policy. In this article, we assimilate evidence to establish HBV on the inclusion health agenda, and consider how this view can inform provision of better approaches to diagnosis, treatment, and prevention. We suggest approaches to redress the unmet need for HBV interventions among excluded populations as an imperative to progress the global goal for the elimination of viral hepatitis as a public health threat.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Virus de la Hepatitis B / Hepatitis B Tipo de estudio: Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Elife Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Virus de la Hepatitis B / Hepatitis B Tipo de estudio: Prognostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Elife Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido